AzTrials
AzTrials

Telomere LengthNCT06357663

Subtle Energy Transmission and Tao Calligraphy Mindfulness in Telomere Length in Peripheral Blood Leukocytes

A study testing Mindfulness practice with Calligraphy in people with Telomere Length and Quality of Life, run by Sha Research Foundation at 1 site in Canada.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Telomere Length in Peripheral Blood Leukocytes A Follow-up Pilot Study The goal of this Pilot clinical trial is to learn if a Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice works to increase Telomere Length in… Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Telomere Length, Quality of Life
What is being tested?
Mindfulness practice with Calligraphy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteCanada
Study dates
15 Jun 2023to 25 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult subjects / patients (age 60 years and over) we expect at 60 years people have already measurable shortening of telomeres
  • Healthy or Ill, with the exception of genetic illnesses and cancer (for which treatments could negatively impact telomeres)
  • Willingness and ability to comply with data collection requirements.
  • Complete submission of required documentation prior to enrollment into the study, including informed consent and consent to release of information.
  • Willingness to allow their data to be used for research purposes and published as deemed fit (while conforming to all applicable privacy laws) by Sha Research Foundation.
  • Willingness to practice the daily calligraphy meditations and follow the protocol.

Who cannot join

  • Not meeting any of the inclusion criteria
  • Bipolar disorders, other serious mental disorders (e.g. schizophrenia, psychosis), genetic illnesses (primarily affected chromosomes), and cancer (treatment could negatively impact telomere during research period)
  • inability to sign consent and follow instructions
  • Unwillingness to participate in data gathering
  • Unable to follow the practice regimen, including the daily calligraphy meditations
  • Pregnant or nursing. Participants who become pregnant during the study will be required to end their participation. (to avoid any, at current time unknown, potential negative effect of the study on the fetus).
  • There are no exclusion criteria placed upon potential subjects related to national origin, culture, ethnicity, race, sex, physical disability, sexual orientation, religion, or spiritual practices.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Sha Research Foundation (Branch)

    North Vancouver, British Columbia, V7R 1P5

Other trials in Canada

About this study

Official title: Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Telomere Length in Peripheral Blood Leukocytes A Follow-up Pilot Study

Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Telomere Length in Peripheral Blood Leukocytes A Follow-up Pilot Study

The goal of this Pilot clinical trial is to learn if a Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice works to increase Telomere Length in Peripheral Blood Leukocytes in adults. The main questions it aims to answer are:

Read more
  • Does A Subtle energy transmission and Tao Calligraphy Mindfulness increase Telomere Length in Peripheral Blood Leukocytes in adults?
  • Will this increase of Telomere Length in Peripheral Blood Leukocytes in adults be statistically significant? Researchers will compare the length of Telomere in peripheral blood Leukocytes at beginning of the mindfulness practices to the length of Telomere in peripheral blood Leukocytes at 3 months and at 9 months of regular daily practices.

Participants will:

  • Receive a transmission of Subtle energy at beginning of practices
  • Visit the Laboratory for a blood sample taken at beginning, at 3 months and at 9 months of practices.
  • Fill the Study Questionnaires at beginning, at 3 months and at 9 months of practices.
  • Practice the Mindfulness with Tao Calligraphy daily 1 hour in the morning and 1 hour in the evening.
Read the detailed description

OBJECTIVES The proposed research is a pilot project based on experiential data obtained from several previous pilot and formal studies by the investigators' research teams and by researchers from other institutions. It is intended to measure the effects of the transmission of subtle energy (blessing), combined with a specific form of meditation, on the length of human telomeres in peripheral blood leucocytes and on overall well-being. The investigators hope that the study will provide further data for individuals seeking an additional modality to prolong life expectancy that could be integrated into conventional medical protocols.

HYPOTHESIS The research null hypothesis is that individuals who receive a subtle energy transmission for improving telomere length in peripheral blood leucocytes and who will also then regularly practice mindfulness with Tao Calligraphy for nine months will (a) have no significant change in telomere length in follow-up analyses as measured by telomere length in peripheral blood leukocytes and will (b) show no improvement of well-being as assessed via the standardized scientific questionnaire Rand SF 36(s) at three and nine months.

Statistical test Anova (using Minitab version 14 and PSPP/SPSS) will be used to evaluate the null hypothesis. The p-value will represent how unlikely the observed data would be if the null hypothesis were actually true and the investigators will use them to reach conclusions. The investigators set the confidence level at 95% and if p <= 0.05, then H0 is rejected.

BACKGROUND Telomeres as Markers of Longevity Background: Telomeres are distinctive protein-DNA structures (repetitive (TTAGGG) sequences) at the end of the chromosomes that are essential for maintaining the integrity and stability of the genome. Telomere length shortens with age (due to multiple cell divisions). The rate of telomere shortening has been found to increase or decrease in association with specific lifestyle factors.

To counteract the loss of telomere repeats with each cell division, germline cells, highly proliferating cells from the skin, the gut, and hematopoietic tissues, as well as tumor cells, express DNAmAge telomerase, an enzyme complex with reverse transcriptase activity, which adds the necessary telomeric DNA (T2AG3 repeats) to the 3-end of the telomeres, protecting their degeneration. Despite expression of telomerase, the telomere length in highly proliferating cells from long-lived species decreases during development and with replication in vitro and with age in vivo. Most likely, telomerase levels in such cells are tightly regulated and are insufficient to make up for the net loss of telomere repeats with cell division.

The telomere length values reflect telomere shortening (resulting from cell divisions, oxidative damage, and other causes) and telomere elongation (mainly resulting from telomerase activity) of the chromosome-specific telomere length inherited in the gametes. Consequently, researchers have two main tools to analyze telomeres, the telomere length and the telomerase.

Although the ability of telomere length measured in peripheral blood to predict life expectancy or monitor mechanisms underlying the aging process is not entirely consistent across studies, telomere length currently remains one of the most widely used biomarkers in epidemiological and clinical studies of aging.

In the protocol of the study, the investigators have discussed several studies using either of these two markers.

The laboratory test used in this study to measure telomere length The average length of telomere repeats can be measured by in situ hybridization and flow cytometry [flow-FISH]. In order to measure the telomere length in granulocytes, naive T cells, memory T cells, B cells, and natural killer (NK)/NKT cells within a blood sample, flow-FISH can be combined with antibody-staining (Multicolor flow-FISH). Most steps in the staining protocol are automated using a 96-well micro-dispenser device. The minimum detectable difference in telomere length and the reproducibility of the method are in the range of 0.2-0.5 kb and measurements can be made with as few as a thousand cells. Automated multicolor flow-FISH greatly facilitates studies of telomere length regulation in subsets of nucleated blood cells, especially when only few cells are available and when differences in telomere length are small.

In Repeat Diagnostics, the laboratory being used for this study, the fluorescent signals from telomeres are assessed on a single cell basis by flow cytometry, with patient results reported for lymphocytes, granulocytes, B-cells, naïve and memory T-cells, and NK cells. All patient telomere length profiles are reported in relationship to age-matched controls and are available for all age ranges from pediatric to geriatric. This telomere reference curve was established by the study of over 800 healthy individuals between birth and 100 years of age. This informative technique allows analysis and comparisons of the telomere length between different cell types and within one cell type, e.g., in differentiating between constitutional deficiencies and specific cell type deficiencies.

The test used in this study to measure overall effect of mindfulness practice A 36-item short-form Quality of Life Questionnaire (SF-36) was constructed to survey health status in the Medical Outcomes Study. The SF-36 was designed for use in clinical practice and research, health policy evaluations, and general population surveys. Although the 12-item short-form of SF-36 would be easier to use, the investigators chose the longer 36-item version, as standard errors were described nearly always to be larger for the 12-item short-form.

The SF-36 includes one multi-item scale that assesses eight health concepts:

  1. limitations in physical activities because of health problems;
  2. limitations in social activities because of physical or emotional problems;
  3. limitations in usual role activities because of physical health problems;
  4. bodily pain;
  5. general mental health (psychological distress and well-being);
  6. limitations in usual role activities because of emotional problems;
  7. vitality (energy and fatigue); and
  8. general health perceptions.

Through a complex calculation, eight scores are derived from answers to 36 questions of SF-36. Finally, these eight scores are linearly transformed to a 0-to-100 scale, with 100 being the best possible outcome.

Chinese calligraphy Chinese calligraphic writing uses an ink-laden brush to create defined configurations of characters. Studies of Chinese calligraphic writing have confirmed its significant effects on psychosomatic conditions, post-traumatic hyper-arousal symptoms, hypertension, and type 2 diabetes.

The investigators chose a Tao Calligraphy practice, which is unique style of moving meditation, wherein mindfulness (heightened awareness) is achieved by the combination of movement and focus on a work of Tao Calligraphy art. In this practice, the subjects do not use an ink-laden brush to write on the paper, but trace the strokes of premade calligraphy with fingers and simultaneously repeat an affirmation (mantra) aloud or silently, which enables them to achieve deep concentration during wakefulness.

Results from the investigators of previous studies confirmed the efficacy of this practice, with significant results in improving overall well-being and chronic conditions as documented by SF MPQ (McGill Pain Questionnaire), by EORTC QLQ-30 (Cancer Quality of Life Questionnaire), and by SF-36 (Quality of Life Questionnaire).

METHOD The study will be performed as a pilot follow-up study. Should the null hypothesis be successfully rejected, this study will be followed by a formal Double Blind Randomized Crossover Study.

As this is a pilot study, there will be no randomization into intervention and control groups. As a control, the investigators will use the "normal" values from the general population. All subjects will receive a transmission and then will be practicing Tao Calligraphy mindfulness daily during the nine-month duration of the study.

The study is conducted on an outpatient basis and includes:

  • Informational telephone or Zoom meeting to clarify inclusion/exclusion criteria, the study design, and the consent/information forms, with signing thereof
  • Initial instructional Zoom meeting to teach the practice of Tao Calligraphy tracing meditation and to deliver the subtle energy transmission (blessing)
  • Laboratory assessment of telomere length in peripheral blood leucocytes of participants
  • Completion of the questionnaires by participants
  • Completion of assessments by a study principal and co-investigators

Laboratory assessment of telomere length in peripheral blood leucocytes:

Laboratory assessment of telomere length in peripheral blood leucocytes will be performed at the entry time point (Time 0), at the end of three months (Time 1), and at the end of nine months (Time 2) for every participant.

Blood samples will be drawn at "Life Labs," a DAP-accredited institution in British Columbia and an accredited institution in the United States, and will be promptly sent by courier to Repeat Diagnostics, Suite 309 - 267 West Esplanade, North Vancouver, BC V7M 1A5 Canada for telomere assessment by Flow FISH.

Reports will be issued to clinical Principal Investigator, Dr. Peter Hudoba.

Improvement of general well-being or clinical well-being as measured by standardized questionnaires:

  1. John Ware's SF-36 Quality of Life questionnaire
  2. Simple follow-up questionnaire of the investigators' own design (to address any additional information participants may have).

Participants will complete both questionnaires online on the Sha Research Foundation website using unique IDs to secure confidentiality.

Each subject of the study will answer all 36 questions at the entry time point (Time 0), at the end of three months (Time 1), and at the end of nine months (Time 2).

From the SF-36 answers, the study statistician will derive 8 scores in a blind fashion. Then, the 8 scores from beginning and end data will be compared to each other and to "normal" values using Anova test. As a control, the investigators will use "normal" values corresponding to the age of each participant at the beginning and at the end of their participation.

The correlation coefficient will be used to determine any correlations between various factors (e.g., effects of age, sex, length, frequency of mindfulness practices, and others) on outcomes and regression analysis to determine the relationship between independent and dependent variables.

Data will be stored on an external hard drive to prevent unauthorized access through the internet.

Being tested
Mindfulness practice with Calligraphy
Keywords
Telomere Length, Leukocytes, Mindfulness, Calligraphy, Quality of Life, Tao
Medical subject headings
Thromboangiitis Obliterans

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness practice with CalligraphyOther

    The unique style of Art Meditation where mindfulness (heightened awareness) is achieved by combination of movement and focus on Chinese Tao Calligraphy while chanting a mantra. The practitioners repeatedly trace the lines of Tao calligraphy with fingers and chant the mantra. This enables them to achieve deep concentration, while maintaining fully alert state. The practice can be done in sitting or standing, depending on the health status and age.

Study groups in NCT06357663
Study groupRoleWhat they receive
SIMPLE FOLLOW UP GROUPOtherEvery subject who is accepted into the study, will receive prior to the inception of practice transmission of pure energy (blessing) and will be instructed on how to practice meditations with Tao Calligraphy. Blood samples will be drawn at DAP accredited institution in British Columbia (Life Labs or Vancouver Coastal Health) and will be promptly sent by currier to Repeat Diagnostics, All participants will have blood samples drawn and Questionnaire filled at the entry time point (Time 0), at the end of 3 months (Time 1), and at the end of 9 months (Time 2).
Receives: Other: Mindfulness practice with Calligraphy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Telomere Length in Peripheral blood leukocytes

    The Change of Telomere Length in Peripheral blood leukocytes after 9 months of Mindfulness Practice with Tao Calligraphy

    Measured: 9 months

Secondary outcomes (1)
  1. Quality of Life by John Ware's SF-36 Quality of Life questionnaire (that produces eight scores with 0-to-100 scale, 100 being the best possible outcome).

    The Change of Quality of Life by John Ware's SF-36 Quality of Life questionnaire after 9 months of Mindfulness Practice with Tao Calligraphy.

    Measured: 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2024
  2. Study start15 Jun 2023
  3. Primary completion31 Jul 2024
  4. Study completion25 Mar 2025

Why it stopped: This was a pilot and we achieved the goal with 12 subjects already.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Model description
The study will be performed as a Pilot follow-up study, should the 0 Hypothesis be successfully rejected, this study will be followed by a formal Double Blind Randomized Crossover Study. We plan subjects may enter the study as a group and will have measurements done within short time frame from each other at beginning and at the end of 3 and 9 months. As this is a pilot study, there will be no randomization into treatment and control group, as a control we will use the "Normal" values of telomere from general population. All subjects will receive a transmission and then will be practicing Tao Calligraphy mindfulness daily during the 9 months. Every subject who is accepted into the study, will have blood sample taken for analysis and will fill Rand SF 36 Questionnaire. Afterwards, will receive transmission of subtle energy by Zhi Gang Sha (or his designee) and will be instructed on how to practice mindfulness with Tao Calligraphy.
Masking
None (open label)
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06357663
Sponsor's protocol ID
Pro00071128
Status last verified
Apr 2025
First submitted
4 Apr 2024
Last updated
15 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Will need to contact IRB if permitted, as this is not in approved protocol

Publications

  • Jacobs TL, Epel ES, Lin J, Blackburn EH, Wolkowitz OM, Bridwell DA, Zanesco AP, Aichele SR, Sahdra BK, MacLean KA, King BG, Shaver PR, Rosenberg EL, Ferrer E, Wallace BA, Saron CD. Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology. 2011 Jun;36(5):664-81. doi: 10.1016/j.psyneuen.2010.09.010. Epub 2010 Oct 29.

    PubMed 21035949
  • Dal Lin C, Marinova M, Brugnolo L, Rubino G, Plebani M, Iliceto S, Tona F. Rapid changes of miRNAs-20, -30, -410, -515, -134, and -183 and telomerase with psychological activity: A one year study on the relaxation response and epistemological considerations. J Tradit Complement Med. 2021 Feb 15;11(5):409-418. doi: 10.1016/j.jtcme.2021.02.005. eCollection 2021 Sep.

    PubMed 34522635
  • Pavanello S, Campisi M, Tona F, Lin CD, Iliceto S. Exploring Epigenetic Age in Response to Intensive Relaxing Training: A Pilot Study to Slow Down Biological Age. Int J Environ Res Public Health. 2019 Aug 23;16(17):3074. doi: 10.3390/ijerph16173074.

    PubMed 31450859
  • Thimmapuram J, Pargament R, Sibliss K, Grim R, Risques R, Toorens E. Effect of heartfulness meditation on burnout, emotional wellness, and telomere length in health care professionals. J Community Hosp Intern Med Perspect. 2017 Mar 31;7(1):21-27. doi: 10.1080/20009666.2016.1270806. eCollection 2017 Jan.

    PubMed 28634520
  • Liu Z, Kuo PL, Horvath S, Crimmins E, Ferrucci L, Levine M. Correction: A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study. PLoS Med. 2019 Feb 25;16(2):e1002760. doi: 10.1371/journal.pmed.1002760. eCollection 2019 Feb.

    PubMed 30802240
  • Liu Z, Kuo PL, Horvath S, Crimmins E, Ferrucci L, Levine M. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study. PLoS Med. 2018 Dec 31;15(12):e1002718. doi: 10.1371/journal.pmed.1002718. eCollection 2018 Dec.

    PubMed 30596641
  • Lu AT, Quach A, Wilson JG, Reiner AP, Aviv A, Raj K, Hou L, Baccarelli AA, Li Y, Stewart JD, Whitsel EA, Assimes TL, Ferrucci L, Horvath S. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019 Jan 21;11(2):303-327. doi: 10.18632/aging.101684.

    PubMed 30669119
  • Field AE, Robertson NA, Wang T, Havas A, Ideker T, Adams PD. DNA Methylation Clocks in Aging: Categories, Causes, and Consequences. Mol Cell. 2018 Sep 20;71(6):882-895. doi: 10.1016/j.molcel.2018.08.008.

    PubMed 30241605
  • Goldman EA, Eick GN, Compton D, Kowal P, Snodgrass JJ, Eisenberg DTA, Sterner KN. Evaluating minimally invasive sample collection methods for telomere length measurement. Am J Hum Biol. 2018 Jan;30(1):10.1002/ajhb.23062. doi: 10.1002/ajhb.23062. Epub 2017 Sep 26.

    PubMed 28949426
  • Ahadi S, Zhou W, Schussler-Fiorenza Rose SM, Sailani MR, Contrepois K, Avina M, Ashland M, Brunet A, Snyder M. Personal aging markers and ageotypes revealed by deep longitudinal profiling. Nat Med. 2020 Jan;26(1):83-90. doi: 10.1038/s41591-019-0719-5. Epub 2020 Jan 13.

    PubMed 31932806
  • Gorenjak V, Akbar S, Stathopoulou MG, Visvikis-Siest S. The future of telomere length in personalized medicine. Front Biosci (Landmark Ed). 2018 Mar 1;23(9):1628-1654. doi: 10.2741/4664.

    PubMed 29293454
  • Notterman DA, Schneper L. Telomere Time-Why We Should Treat Biological Age Cautiously. JAMA Netw Open. 2020 May 1;3(5):e204352. doi: 10.1001/jamanetworkopen.2020.4352. No abstract available.

    PubMed 32364591
  • Koliada AK, Krasnenkov DS, Vaiserman AM. Telomeric aging: mitotic clock or stress indicator? Front Genet. 2015 Mar 16;6:82. doi: 10.3389/fgene.2015.00082. eCollection 2015. No abstract available.

    PubMed 25852738
  • Sanders JL, Newman AB. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? Epidemiol Rev. 2013;35(1):112-31. doi: 10.1093/epirev/mxs008. Epub 2013 Jan 9.

    PubMed 23302541
  • Vaiserman A, Krasnienkov D. Telomere Length as a Marker of Biological Age: State-of-the-Art, Open Issues, and Future Perspectives. Front Genet. 2021 Jan 21;11:630186. doi: 10.3389/fgene.2020.630186. eCollection 2020.

    PubMed 33552142

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness practice with Calligraphy in people with Telomere Length and Quality of Life, run by Sha Research Foundation at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 15 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: This was a pilot and we achieved the goal with 12 subjects already.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Telomere Length in Peripheral blood leukocytes (time frame: 9 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06357663, which also lists 28 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in